1. Home
  2. CARM vs JDZG Comparison

CARM vs JDZG Comparison

Compare CARM & JDZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • JDZG
  • Stock Information
  • Founded
  • CARM 2016
  • JDZG 2020
  • Country
  • CARM United States
  • JDZG China
  • Employees
  • CARM N/A
  • JDZG N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • JDZG Other Consumer Services
  • Sector
  • CARM Health Care
  • JDZG Real Estate
  • Exchange
  • CARM Nasdaq
  • JDZG Nasdaq
  • Market Cap
  • CARM 8.4M
  • JDZG 7.2M
  • IPO Year
  • CARM N/A
  • JDZG 2024
  • Fundamental
  • Price
  • CARM $0.41
  • JDZG $2.45
  • Analyst Decision
  • CARM Hold
  • JDZG
  • Analyst Count
  • CARM 5
  • JDZG 0
  • Target Price
  • CARM $0.90
  • JDZG N/A
  • AVG Volume (30 Days)
  • CARM 42.2M
  • JDZG 107.4K
  • Earning Date
  • CARM 08-07-2025
  • JDZG 07-15-2025
  • Dividend Yield
  • CARM N/A
  • JDZG N/A
  • EPS Growth
  • CARM N/A
  • JDZG N/A
  • EPS
  • CARM N/A
  • JDZG 0.25
  • Revenue
  • CARM $19,964,000.00
  • JDZG $2,567,741.00
  • Revenue This Year
  • CARM N/A
  • JDZG N/A
  • Revenue Next Year
  • CARM N/A
  • JDZG N/A
  • P/E Ratio
  • CARM N/A
  • JDZG $9.97
  • Revenue Growth
  • CARM 32.45
  • JDZG 20.36
  • 52 Week Low
  • CARM $0.14
  • JDZG $1.61
  • 52 Week High
  • CARM $1.42
  • JDZG $21.28
  • Technical
  • Relative Strength Index (RSI)
  • CARM 51.65
  • JDZG N/A
  • Support Level
  • CARM $0.37
  • JDZG N/A
  • Resistance Level
  • CARM $0.44
  • JDZG N/A
  • Average True Range (ATR)
  • CARM 0.07
  • JDZG 0.00
  • MACD
  • CARM -0.01
  • JDZG 0.00
  • Stochastic Oscillator
  • CARM 10.37
  • JDZG 0.00

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About JDZG JIADE LIMITED Common stock

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

Share on Social Networks: